SBI Protect Powder 5.3 oz

SBI Protect Powder 5.3 oz by Ortho Molecular Products

SBI Protect Powder 5.3 oz, designed by Ortho Molecular Products, is a one-of-a-kind supplement for gastrointestinal health support.* It is a purified, diary-free source of IgG (immunoglobulin G), a substance that may improve your general immunity and gut health.* As such, SBI Protect Powder 5.3 oz may be chosen by you if you wish to improve your resistance to bacteria and viruses but also to maintain a healthy microbial balance.*

Who May Take SBI Protect Powder 5.3 oz?

You may take SBI Protect Powder 5.3 oz if you:

• often suffer from infections, namely:
• gastrointestinal infections*
• ear infections*
• soar-throat-derived infections*
• you have an IgG deficiency*

The Impact of SBI Protect Powder 5.3 oz on Your Body

SBI Protect Powder 5.3 by Ortho Molecular Products may have the following effects on your body:

• improving immunity and protection against both viruses and bacteria*
• supporting GI barrier health and integrity*
• maintaining normal inflammatory balance

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about SBI Protect Powder 5.3 oz.

Recommendation:
Ortho Molecular Products suggest taking 1 scoop (2.5 grams)of SBI Protect Powder in 4 ounces of water or the beverage of your choice 2 times daily or as recommended by your health care professional.

Serving Size: 1 Scoop (2.5 grams)
Servings Per Container: approx. 60

Amount Per Serving:
Calories 10
Protein 2 g
Serum-Derived Bovine 2.5 g
Immunoglobulin Concentrate (ImmunoLin®)
Immunoglobulin G (IgG) 1.2 g

Does Not Contain: Gluten, corn, yeast, artificial colors and flavors.

Cautions: If you are pregnant of nursing, consult your health care professional before taking this product.

Click here to view Product Info Sheet

References:

1. Asmuth, D. M., Ma, Z. M., Albanese, A., Sandler, N. G., Devaraj, S., Knight, T. H., et al. (2013). Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy. AIDS, 27, 2207-2217. https://doi.org/10.1097/QAD.0b013e328363e4d5
2. Asmuth, D. M., Somsouk, M., Hunt, P., Ma, Z. M., Miller, C. L., Hinkle, J., et al. (2015). Serum-derived bovine immunoglobulin protein isolate increases peripheral and mucosal CD4+ T-cell counts in patients with HIV enteropathy. 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (AIDS 2015); MOAA02; Vancouver, Canada, 19-22 July. Retrieved from http://www.ias2015.org/WebContent/File/IAS_2015__MED2.pdf
3. Bosi, P., Casini, L., Finamore, A., Cremokolini, C., Merialdi, G., Trevisi, P., et al. (2004). Spray-dried plasma improves growth performance and reduces inflammatory status of weaned pigs challenged with enterotoxigenic Escherichia coli K88. Journal of Animal Science, 82(6), 1764-1772. https://doi.org/10.2527/2004.8261764x
4. Detzel, C. J., Horgan, A., Henderson, A. L., Petschow, B. W., Warner, C. D., Maas, K. J., & Weaver, E. M. (2015). Bovine immunoglobulin/protein isolate binds pro-inflammatory bacterial compounds and prevents immune activation in an intestinal co-culture model. PLOS ONE, 10(4), e0120278. https://doi.org/10.1371/journal.pone.0120278
5. Gobbo, L. C. D., Imamura, F., Wu, J. H., Otto, M. C. D. O., Chiuve, S. E., & Mozaffarian, D. (2015). Dietary intervention with serum-derived bovine immunoglobulins protects barrier function in a mouse model of colitis. American Journal of Physiology - Gastrointestinal and Liver Physiology, 308(12), G1012-G1018. https://doi.org/10.1152/ajpgi.00378.2014
6. Henderson, A. L., Brand, M. W., Darling, R. J., Maas, K. J., Detzel, C. J., Hostetter, J., et al. (2015). Attenuation of colitis by serum-derived bovine immunoglobulin/protein isolate in a defined microbiota mouse model. Digestive Diseases and Sciences, 60(11), 3293-3303. https://doi.org/10.1007/s10620-015-3732-5
7. Jasion, V. S., & Burnett, B. P. (2015). Survival and digestibility of orally administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humans. Nutrition Journal, 14, 22. https://doi.org/10.1186/s12937-015-0010-7
8. Petschow, B. W., Burnett, B. P., Shaw, A. L., Weaver, E. M., & Klein, G. L. (2014). Serum-derived bovine immunoglobulin/protein isolate: Postulated mechanism of action for management of enteropathy. Clinical and Experimental Gastroenterology, 7, 181-190. https://doi.org/10.2147/CEG.S62823
9. Wilson, D., Evans, M. D., Weaver, E., Shaw, A. L., & Klein, G. L. (2013). Evaluation of serum-derived bovine immunoglobulin protein isolate in subjects with diarrhea-predominant irritable bowel syndrome. Clinical Medicine Insights: Gastroenterology, 6, 49-60. https://doi.org/10.4137/CMGI.S12835
10. Roussouw, J., & Brummelen, R. (n.d.). The bioavailability of four magnesium preparations. Publication pending.